---
layout: minimal-medicine
title: Antihemophilic Factor (Recombinant)
---

# Antihemophilic Factor (Recombinant)
### Generic Name
Antihemophilic Factor (Recombinant)

### Usage

Antihemophilic factor (recombinant) is a crucial medication for individuals with hemophilia A, a condition characterized by insufficient levels of clotting factor VIII in the blood, leading to prolonged bleeding.  Its primary use is to prevent and control bleeding episodes in both adults and children with hemophilia A. This includes managing spontaneous bleeds and those resulting from injuries or procedures.  

Importantly, it's also used for surgical prophylaxis—preventing bleeding during and after surgery—and for routine prophylactic treatment.  Routine prophylaxis aims to reduce the frequency of bleeding episodes and, in children without pre-existing joint damage, to minimize the risk of long-term joint damage, a significant complication of hemophilia A.  This preventative approach is key in improving the quality of life for those with hemophilia A.  Note that this medication is *not* indicated for the treatment of von Willebrand disease.

### Dosage

Dosage of antihemophilic factor (recombinant) is highly individualized and depends on several factors, including the patient's weight, the severity of the bleeding episode (or the need for prophylaxis), and their individual response to the medication.  Coagulation studies (measuring factor VIII levels) are used to guide dosage.  It's administered intravenously (IV).

**Adults:** Dosage calculations are complex and involve determining a desired peak factor VIII level (based on the location and severity of bleeding, following World Federation of Hemophilia [WFH] guidelines) and the patient's baseline level.  A formula is then used to calculate the required dose.  Treatment may involve intermittent bolus dosing (single doses given at intervals) or continuous infusion for prolonged treatment (e.g., post-surgery).  The frequency of dosing depends on the individual patient and the response to treatment.  For routine prophylaxis, the goal is to maintain a certain trough (lowest) level of factor VIII between doses.

**Children:**  Pediatric dosing is also individualized, using similar principles to adult dosing but with adjustments based on age and weight.  Dosage formulas are used, often adapting to the type of bleed or surgical procedure.  The WFH guidelines provide recommendations for peak factor VIII levels depending on the location of the bleed.  Continuous infusions may be considered for prolonged treatment periods in children as well.  Again, frequency is determined based on the child's response to the medication and the severity of their condition.


### Side Effects

Common side effects (occurring in more than 10% of patients) can include headache, itching, skin rash, fever, and upper respiratory infections. Less common but potentially serious side effects include allergic reactions (including anaphylaxis), and the development of antibodies against factor VIII (inhibitors), which can reduce the effectiveness of treatment. Other side effects, with varying frequency, may include gastrointestinal issues, cardiovascular symptoms, and local reactions at the injection site.  It's crucial to report any unusual or concerning side effects to a healthcare professional immediately.

*   Headache
*   Pruritus (itching)
*   Skin rash
*   Urticaria (hives)
*   Increased factor VIII inhibitors
*   Catheter infection
*   Arthralgia (joint pain)
*   Cough
*   Nasopharyngitis
*   Upper respiratory tract infection
*   Fever
*   And many others (see product labeling for a complete list)

### How it Works

Antihemophilic factor (recombinant) is a manufactured version of factor VIII, a protein essential for blood clotting.  In individuals with hemophilia A, factor VIII is either missing or deficient.  This medication replaces the missing factor VIII, enabling the blood to clot properly and stop bleeding. It works by participating in a complex cascade of reactions that ultimately lead to the formation of a stable blood clot.

### Precautions

*   **Hypersensitivity:**  This medication is contraindicated (absolutely forbidden) in patients with a known hypersensitivity (allergic reaction) to antihemophilic factor, mouse or hamster protein, bovine protein, or any component of the formulation.
*   **Inhibitor Development:** There's a risk of developing inhibitors (antibodies) against factor VIII, making the medication less effective.  This requires close monitoring and potential adjustments to treatment.
*   **Allergic Reactions:**  Serious allergic reactions, including anaphylaxis, are possible and require immediate medical attention.
*   **Pregnancy and Breastfeeding:**  Use during pregnancy should only occur if clearly needed, and the benefits outweigh the risks.  The excretion of the medication into breast milk is unknown.
*   **Interactions:**  While no significant drug interactions are currently known, it's crucial to inform your doctor about all medications you are taking.
*   **Specific populations (elderly and children):** Close monitoring is required in specific populations like elderly and children due to the increased risks.

### FAQs

*   **Q: How is antihemophilic factor (recombinant) administered?**  A: It is administered intravenously (IV), either as a bolus injection or a continuous infusion.

*   **Q: How long does it take to work?** A: The onset of action varies depending on the dose and administration method.  Peak factor VIII levels are typically measured 15-30 minutes after infusion for bolus injections.

*   **Q: How is it stored?** A: Storage instructions vary depending on the specific product; always follow the manufacturer's guidelines provided with the medication.

*   **Q: What should I do if I miss a dose?** A: Contact your healthcare provider immediately to discuss how to proceed.

*   **Q: Are there long-term effects?** A: Long-term effects are generally related to the underlying condition of hemophilia A.  Prophylactic use aims to minimize long-term complications like joint damage.  Close monitoring by your healthcare team is important.

*   **Q: What are the warning signs of a serious side effect?** A: Warning signs include difficulty breathing, swelling of the face or throat, severe allergic reactions (hives, itching, rash), and any unexpected or severe bleeding. Seek immediate medical attention if you experience these symptoms.


**Disclaimer:**  This information is for general knowledge and does not constitute medical advice.  Always consult with a healthcare professional for diagnosis and treatment of any medical condition.  The information provided here should not be considered a substitute for the complete prescribing information provided by the manufacturer of a specific antihemophilic factor (recombinant) product. Always refer to the official product labeling for detailed dosage instructions and potential side effects.
